Dr. Mary Klotman reappointed Dean of the School of Medicine

Dear colleagues,

We are pleased to share with you that Mary E. Klotman, MD, has been reappointed for a second five-year term as Dean of Duke University School of Medicine, Vice Chancellor for Health Affairs at Duke University and Director Academic of Duke University Health System. His new term begins on July 1, 2022.

Dr. Klotman led Duke University School of Medicine through one of the most challenging times in our more than 90-year history. Through her leadership and the extraordinary contributions of our faculty and staff, she will also be remembered for her remarkable achievements. Dr. Klotman was first named Dean of Duke University School of Medicine in 2017, after serving nearly seven years with distinction as chair of Duke’s Department of Medicine. Over the past five years, under Dean Klotman’s leadership and in partnership with chairs, center and institute directors, faculty, vendors, students, and staff, the School of Medicine has made strides significant in achieving the school’s priority missions of excellence in patient care. care, discovery and translation, education and community health improvement.

From the outset, Dean Klotman embraced a “One Duke” philosophy and commitment to supporting and serving faculty, staff, and students to ensure their success and the continued prominence of the School of Medicine. Currently ranked sixth among all medical schools in the nation for research and third for NIH funding, the school is home to an outstanding community of faculty, staff, and students nationally recognized as innovators and leaders. , and honored for their achievements.

Dean Klotman led the School of Medicine during the COVID-19 pandemic as faculty, staff, and students focused on urgent needs, making transformative contributions in treatment, testing and monitoring, development vaccines, mitigation and safety guidance, program and training, and community partnerships.

In 2020, under the leadership of Dr. Klotman and in partnership with hundreds of faculty, staff and students, the school began developing its first strategic plan to dismantle racism and advance equity , diversity and inclusion as part of “Moments to Movement”. Officially launched in 2021, the plan reflects the school’s commitment to tangible and lasting change at the institutional level and in our wider communities.

In 2021, the School of Medicine, in partnership with Duke University Health System and the PDC, launched a Clinical Enterprise Strategic Plan. In the spring of 2022, a key milestone in this plan was achieved with a formal agreement to create a new integrated clinical practice – to ensure Duke Health’s continued leadership in clinical excellence and support of the academic mission.

Dean Klotman’s commitment to scientific excellence is reflected in his efforts to retain and recruit outstanding research faculty and provide ongoing support to the research community. During his tenure, eight new scholars were recruited through the Duke Science and Technology initiative, and since 2017 the School of Medicine has constructed new state-of-the-art research facilities, including the Chesterfield Building, the Medical Science Research Building (MSRB) III and Duke’s first research campus in Research Triangle Park: Duke Research & Discovery@RTP.

A national leader in science and academic medicine, Dean Klotman is a Fellow of the National Academy of Medicine and a Fellow of the American Academy of Arts and Sciences. She is past president of the Association of American Physicians and past president of the Association of Professors of Medicine. A widely recognized authority on HIV, Dean Klotman and his lab focus specifically on HIV-associated kidney disease. More recently, she and her team defined the role of integrase-deficient lentiviral vectors for HIV vaccine delivery.

We couldn’t be happier to have Dr. Klotman as head of the School of Medicine. Please join us in congratulating her on this well-deserved renewal.


A. Eugene Washington, MD
Chancellor of Health Affairs, Duke University
President and CEO, Duke University Health System

Sally Kornbluth, PhD
President, Duke University


Leave a Comment